We’ve received many papers on nanocarriers for drug delivery this past year but few to none on nanocarriers for biodetoxification.

In our November issue, the progress article
discusses the use of nanocarriers to scavenge toxic drugs/agents as a way to manage the overdose of drugs or accidental exposures to toxic chemicals.

Liposomes were first proposed for treating poisoning almost 35 years ago…but only one system so far has reached the clinical stage partly because combining properties such as biocompatibility, long circulation time, stability and high extraction efficiency is not trivial.

How can the advances in nanotechnology be used to progress this field forward?

Thoughts/comments on this topic? Post them here and start a discussion.